Table 3 Course Readings
Bhutta ZA (2002) Ethics in international health research: a perspective from the developing world. Bull World Health Organ.;80(2):114–20. Review. |
|---|
Bloom BR & Trach D (2001) Genetics and Developing Countries. BMJ;322:1006–7. |
Capron AM (2001) Stem Cells: Ethics, Law and Politics. Biotech Law Report;5:678–699. |
Collins FS, Green ED, Guttmacher AE, Guyer MS; US National Human Genome Research Institute. (2003) A vision for the future of genomics research. Nature.24;422(6934):835–47. |
Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. (2002) Top ten biotechnologies for improving health in developing countries. Nat Genet.;32(2):229–32. |
Gold ER (2003) SARS genome patent: symptom or disease? Lancet.;361(9374):2002–3. |
Juma C & Konde V (2002). The New Bioeconomy: Industrial and Environmental Biotechnology in Developing Countries. Geneva, Switzerland: United Nations, July 2002. |
Lundvall B, Johnson B, Andersen EA, Dalum B (2002) National systems of production, innovation and competence building. Research Policy;31:213–231 |
Nasim A (2000) Ethical Issues of the Human Genome Project: An Islamic Perspective in Bioethics in Asia. Eubios Ethics Institute Eds: N Fujiki and DRJ Macer p. 209–214 |
Pang T & Weatherall D (2002) Genomics and Global Health. BMJ;324:p.1051–52 |
Singer PA, Daar AS (2001) Harnessing genomics and biotechnology to improve global health equity. Science;294(5540):87–9. |
Sulston J (2003) Beyond release: the equitable use of genomic information. Lancet.;362(9381):400–2. |
Thorsteinsdóttir H, Daar AS, Smith RD, Singer PA (2003) Genomics – a global public good? Lancet.;361(9361):891–2. |
Time to Unite Islam and Science. Nature. 2003 Mar 13;422(6928):99. |